Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Amendment: Biohit Oyj Managers' Transactions


Posted on: 27 Aug 18

BIOHIT OYJ           AMENDMENT: MANAGERS’ TRANSACTIONS                              
27 AUGUST 2018  At 13.00 local time (EET)


Biohit Oyj: Managers' Transactions

Person subject to the notification requirement
Name:                                   
Ilari Patrakka
Position:                                Other Senior Management

Issuer:                                   Biohit Oyj
LEI:                                        74370089ATTSNBXJVT29
__________________________________________________

Notification type:                 AMENDMENT
Reference number:              74370089ATTSNBXJVT29_20180824112013_5

Transaction date:                 2018-08-22
Venue:                                   OFF-EXCHANGE TRANSACTIONS (XOFF)

Nature of the transaction:    SUBSCRIPTION 
(X) Linked to stock option programme
Instrument type:                    SHARE
ISIN:                                        FI4000219324

Transaction details
Volume: 1,116 
Unit price: 2.2766 EUR

Aggregated transactions
Volume: 1,116 
Volume weighted average price: 2.2766 EUR

Biohit Oyj


Semi Korpela
CEO


For additional information: 
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi

GlobeNewswire
globenewswire.com

Last updated on: 27/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.